StockData
Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc. (TPST) income statement

TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.31−0.00 (-1.10%)

Close on Nov 19, 2026Market cap $4.53MP/E –Yield –

See a number that looks wrong?